Katalyze AI thinks the future of pharma operations is teams of AI agents

Katalyze AI, co-founded by a former Sanofi leader and WFHomie co-founder, raised $10.5 million USD to deploy teams of AI agents that accelerate pharmaceutical drug development operations.

WFHomie co-founder and former Sanofi leader close $10.5 million USD to speed drug development. The post Katalyze AI thinks the future of pharma operations is teams of AI agents first appeared on BetaKit.